Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 19
Gene Symbol: ABCA1
ABCA1
0.010 GeneticVariation group BEFREE In conclusion, we identified a novel ABC1 domain-localized pathogenic mutation responsible for ADCK4-GN, further supporting the importance of the C-terminal portion of ADCK4. 30352687 2018
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 GeneticVariation group BEFREE Angiotensin-converting enzyme (ACE) I/D polymorphism has been implicated as a genetic marker for progression of glomerular disease. 12172761 2002
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 Biomarker group BEFREE Studies conducted over the last decade demonstrated variable therapeutic efficacy of angiotensin converting enzyme (ACE) inhibitor on the progression of glomerular diseases, including IgA nephropathy. 7593601 1995
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 GeneticVariation group BEFREE The presence of the D (deletion) allele at the angiotensin converting enzyme (ACE) gene has been associated with a) adverse vascular events contributing to early mortality and b) progressive deterioration of renal function in a variety of chronic glomerular diseases. 9710341 1998
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 AlteredExpression group BEFREE The D allele, which is associated with higher plasma ACE levels, and the level of ACE in plasma, were found in case control studies to be associated with an increased risk of myocardial infarction, an increased risk of diabetic nephropathy in type I diabetic patients, and a faster rate of renal function degradation in glomerular diseases. 9247746 1997
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 Biomarker group BEFREE Angiotensin-converting enzyme (ACE) inhibitors are known to reduce blood pressure and proteinuria in a variety of different glomerular diseases. 9661139 1998
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 GeneticVariation group BEFREE The angiotensin-converting enzyme DD genotype is associated with glomerulopathy lesions in type 2 diabetes. 11756350 2002
Entrez Id: 1636
Gene Symbol: ACE
ACE
0.070 GeneticVariation group BEFREE Insertion/deletion polymorphisms of the ACE gene may play some role in the genesis and progression of MesPGN. 19937361 2010
Entrez Id: 59272
Gene Symbol: ACE2
ACE2
0.010 Biomarker group BEFREE ACE2 as therapy for glomerular disease: the devil is in the detail. 28501298 2017
Entrez Id: 2182
Gene Symbol: ACSL4
ACSL4
0.100 Biomarker group HPO
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.020 AlteredExpression group BEFREE Mesangial cells during embryonic development and glomerular disease express smooth muscle alpha-actin (alpha-SMA). 9767533 1998
Entrez Id: 60
Gene Symbol: ACTB
ACTB
0.020 Biomarker group BEFREE Podocyte malfunction is central to glomerular diseases and is marked by defective podocyte intercellular junctions and actin cytoskeletal dynamics. 29162704 2018
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 Biomarker group BEFREE Glomerular diseases: FSGS. 23990165 2014
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 Biomarker group BEFREE Patients transplanted between 2002 and 2016, comparing FSGS diagnosis vs other glomerular diseases. 31169337 2019
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 Biomarker group BEFREE In conclusion, ADCK4-related glomerulopathy is an important novel differential diagnosis in adolescents with SRNS/FSGS and/or CKD of unknown origin. 25967120 2016
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 AlteredExpression group BEFREE Furthermore, we identify a close correlation between the levels of α-actinin-4 and CLP36, which form a complex in normal podocytes, in human glomerular diseases. siRNA-mediated depletion of α-actinin-4 in human podocytes resulted in a marked reduction of the CLP36 level. 21680739 2011
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 AlteredExpression group BEFREE Mice with altered alpha-actinin-4 expression have distinct morphologic patterns of glomerular disease. 18185509 2008
Entrez Id: 81
Gene Symbol: ACTN4
ACTN4
0.060 Biomarker group BEFREE Smad7 is upregulated in podocytes in all examined glomerular diseases (focal segmental glomerulosclerosis [FSGS], minimal-change disease [MCD], membranous nephropathy [MNP], lupus nephritis [LN], and diabetic nephropathy [DN]) with a statistically significant upregulation in "classical" podocyte-diseases such as FSGS and MCD. 12397035 2002
Entrez Id: 10555
Gene Symbol: AGPAT2
AGPAT2
0.100 Biomarker group HPO
Entrez Id: 183
Gene Symbol: AGT
AGT
0.050 Biomarker group BEFREE The Role of Angiotensin II in Parietal Epithelial Cell Proliferation and Crescent Formation in Glomerular Diseases. 28807596 2017
Entrez Id: 183
Gene Symbol: AGT
AGT
0.050 Biomarker group BEFREE Thus, genetic determinants that affect renal angiotensin II and kinin productions are risk factors for the progression of glomerular disease in uncontrolled insulin-dependent diabetic patients. 9120002 1997
Entrez Id: 183
Gene Symbol: AGT
AGT
0.050 Biomarker group BEFREE Angiotensin II (AngII) is a key contributor to glomerular disease and may regulate TRPC6 expression in nonrenal cells. 21839714 2011
Entrez Id: 183
Gene Symbol: AGT
AGT
0.050 Biomarker group BEFREE The augmented AngII-mediated kidney injury observed in association with increased intrarenal AngII accumulation in the absence of APA suggests a protective metabolizing role of APA in AngII-mediated glomerular diseases. 28202497 2017
Entrez Id: 183
Gene Symbol: AGT
AGT
0.050 Biomarker group BEFREE We have reported that tubular epithelial cell injury caused by renal ischemia-reperfusion is attenuated in conditional VHL knockout (VHL-KO) mice and also that induction of hypoxia-inducible factor (HIF) suppresses angiotensin II-accelerated Habu snake venom (HV) glomerulonephropathy in rats. 21493813 2011
Entrez Id: 231
Gene Symbol: AKR1B1
AKR1B1
0.010 GeneticVariation group BEFREE Association of glomerulopathy with the 5'-end polymorphism of the aldose reductase gene and renal insufficiency in type 2 diabetic patients. 15504980 2004